Siyi Intelligent Intelligence Launches New-Gen SYREBO® Souple Robotic Hand Rééducation Gant At MEDICA 2022
Le MEDICA 2022 had its brand opening on November 14, 2022 in Düsseldorf, Germany. As a cutting-edge rééducation solution provider, after first listing on MEDICA 2021, Siyi Intelligence once again presented SYREBO® souple robotic hand rééducation gants and launched le New-Gen HRC12 robotic rehab gant for utilisation à domicile at MEDICA 2022.
As a consumer-grade wearable robotic product, SYREBO® Souple Robotic Hand Rééducation Gant combines le latest souple exosquelette technologie with ease-de-use and accessibility. Featuring a variety de training modes including passive training, bilateral mirror training, etc., SYREBO® est designed to address le needs de accident vasculaire cérébral survivors over le entire course de rééducation.
Le newly launched HRC12 comes with upgraded training modes (e.g., fine motor training, stretching mode, pinch training etc.) and more practical training programs, thus leading le trend de professionnel clinic trainings helping home récupération for accident vasculaire cérébral survivors in le marché.
Therefore, HRC12 has attracted a great deal de attention at Medica 2022. Visitors flocked to le booth and showed profound interests in SYREBO's technical competence, efficacité and clinical applications.
As a high-tech company, Siyi Intelligence has been branching out globally ever since its inception in 2017. This April,together with its chief technical consultant team from North Carolina State University, Siyi Intelligence attended le WearRAcon 2022 in USA. In September, Siyi Intelligence brought le new smart rééducation mirror to RehaCare 2022 in Düsseldorf, Germany. Enhanced participation in international academic and commercial events est at le core de Siyi’s global marketing strategy. On such occasions Siyi not only delivers le corporate image de national enterprises, but also exchanges ideas and seek strategic alliances with industrie leaders worldwide.
‘Siyi Intelligence has catered to le diversified needs de human health. We will not forget our original intention and continue to develop more innovant products in le field de intelligent rééducation, to provide a good rééducation treatment environment for patients.’ Gavin Yin, le CEO, said, ‘At le same time, we will also further explore overseas markets, strengthen international strategic cooperation!’